APP and Dravet syndrome: However, the overall 4x elevation of Aβ40 in DS individuals over 40 years of age compared to AD was not consistently explained by CAA, suggesting altered APP processing favoring Aβ40 or shifted targeting of Aβ40 to plaques in AD-DS.